PlainRecalls
FDA Devices Moderate Class II Ongoing

Revaclear 400 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.

Reported: December 28, 2022 Initiated: November 23, 2022 #Z-0763-2023

Product Description

Revaclear 400 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.

Reason for Recall

Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak

Details

Units Affected
6,338,280 units
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, China, Australia, New Zealand, Austria, Egypt, France, Germany, Ireland, Italy, Morocco, Qatar, Saudi Arabia, South Africa, Spain, United Kingdom, Bahamas, Barbados, Belize, Bermuda, Colombia, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Panama, St. Thomas, Trinidad and Tobago.
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Revaclear 400 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.. Recalled by Baxter Healthcare Corporation. Units affected: 6,338,280 units.
Why was this product recalled?
Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak
Which agency issued this recall?
This recall was issued by the FDA Devices on December 28, 2022. Severity: Moderate. Recall number: Z-0763-2023.